{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:26:37Z","timestamp":1778732797080,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01475-4","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:02:37Z","timestamp":1662444157000},"page":"1034-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients"],"prefix":"10.1007","volume":"22","author":[{"given":"Chiara","family":"Pane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Trinchillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Puorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-6317","authenticated-orcid":false,"given":"Francesco","family":"Sacc\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia Valeria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"1475_CR1","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1093\/hmg\/ddh324","volume":"13","author":"O Stehling","year":"2004","unstructured":"Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet. 2004;13:3007\u201315.","journal-title":"Hum Mol Genet"},{"key":"1475_CR2","doi-asserted-by":"publisher","first-page":"e17627","DOI":"10.1371\/journal.pone.0017627","volume":"6","author":"F Sacca","year":"2011","unstructured":"Sacca F, Puorro G, Antenora A, et al. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. PLoS One. 2011;6:e17627.","journal-title":"PLoS One"},{"key":"1475_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11845-012-0808-7","volume":"181","author":"RM Payne","year":"2012","unstructured":"Payne RM, Peverill RE. Cardiomyopathy of Friedreich\u2019s ataxia (FRDA). Ir J Med Sci. 2012;181:569\u201370.","journal-title":"Ir J Med Sci"},{"key":"1475_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11845-011-0744-y","volume":"180","author":"T Bourke","year":"2011","unstructured":"Bourke T, Keane D. Friedreich\u2019s Ataxia: a review from a cardiology perspective. Ir J Med Sci. 2011;180:799\u2013805.","journal-title":"Ir J Med Sci"},{"key":"1475_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1525-1594.2010.01140.x","volume":"34","author":"KO Coskun","year":"2010","unstructured":"Coskun KO, Popov AF, Schmitto JD, et al. Feasibility of implantable cardioverter defibrillator treatment in five patients with familial Friedreich\u2019s ataxia\u2013a case series. Artif Organs. 2010;34:1061\u20135.","journal-title":"Artif Organs"},{"issue":"5","key":"1475_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehq443","volume":"32","author":"SV Raman","year":"2011","unstructured":"Raman SV, Phatak K, Hoyle JC, et al. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur Heart J. 2011;32(5):561\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehq443.","journal-title":"Eur Heart J"},{"key":"1475_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","volume":"110","author":"R Querejeta","year":"2004","unstructured":"Querejeta R, L\u00f3pez B, Gonz\u00e1lez A, et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation. 2004;110:1263\u20138.","journal-title":"Circulation"},{"key":"1475_CR8","doi-asserted-by":"crossref","unstructured":"Lee YR, Briggs MT, Condina MR, et al. Mass spectrometry imaging as a potential tool to investigate human\u00a0osteoarthritis at the tissue level.\u00a0Int J Mol Sci 2020;21:6414.\u00a0","DOI":"10.3390\/ijms21176414"},{"key":"1475_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1253\/circj.71.929","volume":"71","author":"T Kitahara","year":"2007","unstructured":"Kitahara T, Takeishi Y, Arimoto T, et al. Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function. Circ J. 2007;71:929\u201335.","journal-title":"Circ J"},{"key":"1475_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jchf.2013.04.003","volume":"1","author":"A Cittadini","year":"2013","unstructured":"Cittadini A, Marra AM, Arcopinto M, et al. Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. JACC Heart Fail. 2013;1:325\u201330.","journal-title":"JACC Heart Fail"},{"key":"1475_CR11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"issue":"Suppl 1","key":"1475_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/jnc.12318","volume":"126","author":"K B\u00fcrk","year":"2013","unstructured":"B\u00fcrk K, Schulz SR, Schulz JB. Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales. J Neurochem. 2013;126(Suppl 1):118\u201324.","journal-title":"J Neurochem"},{"key":"1475_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/jc.2006-1706","volume":"92","author":"M Rauchenzauner","year":"2007","unstructured":"Rauchenzauner M, Schmid A, Heinz-Erian P, et al. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab. 2007;92:443\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1475_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho CY, L\u00f3pez B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363:552\u201363.","journal-title":"N Engl J Med"},{"key":"1475_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.14503\/THIJ-14-4198","volume":"43","author":"N Mehta","year":"2016","unstructured":"Mehta N, Chacko P, Jin J, et al. Serum versus imaging biomarkers in Friedreich ataxia to indicate left ventricular remodeling and outcomes. Tex Heart Inst J. 2016;43:305\u201310.","journal-title":"Tex Heart Inst J"},{"key":"1475_CR16","doi-asserted-by":"publisher","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","volume":"11","author":"L Kannan","year":"2018","unstructured":"Kannan L, Shaw PA, Morley MP, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail. 2018;11:e005266.","journal-title":"Circ Heart Fail"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01475-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T08:37:41Z","timestamp":1694075861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01475-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01475-4","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"30 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Francesco Sacc\u00e0 received public speaking honoraria from Alexion, Argenx, Biogen, Mylan, Novartis, Roche, Sanofi, Teva; he also received compensation for Advisory boards or consultation fees from Alexion, Almirall, Argenx, Avexis, Biogen, Forward Pharma, Lexeo Therapeutics, Merk, Novartis, Novatek, Roche, Sanofi, and Takeda. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}